Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tamoxifen not likely to prevent many breast cancers in at-risk women

28.09.2004


Research has shown that the drug tamoxifen citrate not only helps prevent recurrence of breast cancer, but it also can keep the deadly disease from occurring in the first place in some women.



But a new University of North Carolina at Chapel Hill study indicates it’s unlikely that tamoxifen will ever be given widely to women to prevent breast cancer. That’s because the drug would avert only a maximum of 6 percent to 8.3 percent of breast tumors in eligible women, UNC School of Medicine researchers have found. "Our calculations showed that tamoxifen’s possibly harmful side effects, including blood clots and stroke, would rule out some 90 percent of women who might benefit from taking it each day," said Dr. Russell P Harris, associate professor of medicine at UNC. A report on the study appears in the latest issue of the Archives of Internal Medicine.

Besides Harris, a member of UNC’s Lineberger Comprehensive Cancer Center, authors are principal investigator Dr. Carmen L. Lewis, assistant professor of medicine at UNC; Dr. Linda S. Kinsinger, assistant director of the VA Center for Health Promotion and Disease Prevention; and Robert J. Schwartz, a computer programmer at UNC’s Cecil G. Sheps Center for Health Services Research.


The study involved having 605 women, ages 40 to 69, in 10 general internal medicine practices in North Carolina, fill out questionnaires about their health and family histories of breast cancer. Then, using a proven formula for assessing breast cancer incidence and factoring in the women’s responses, researchers determined the expected number of cases that would occur over the next five years.

They found that only a relatively small number of women in primary care practices would be eligible for the chemopreventive therapy because of existing conditions such as high blood pressure and diabetes and other risk factors, Harris said. Since the majority of women never develop breast cancer anyway, the percentage of actual cancers prevented would be small.

"Screening mammography, which is useful, is not the whole answer to preventing breast cancer deaths, and our new work shows that tamoxifen won’t be either," he said. "On the other hand, in a message to the research community, tamoxifen has shown us that if we can find other chemopreventive agents that don’t have all the side effects, then we could have greater success and save more lives."

Tamoxifen works in women by blocking what’s known as the estrogen receptor that allows the hormone to work, the physician said. Most breast cancer development is dependent on estrogen.

Limitations of the research were that the number of women in each age category of the overall group were small, and black women, women with less education and those with no health insurance were not well represented in the sample, Harris said. Similar studies with larger numbers of subjects would help confirm the results.

David Williamson | EurekAlert!
Further information:
http://www.unc.edu

More articles from Health and Medicine:

nachricht Penn studies find promise for innovations in liquid biopsies
30.03.2017 | University of Pennsylvania School of Medicine

nachricht 'On-off switch' brings researchers a step closer to potential HIV vaccine
30.03.2017 | University of Nebraska-Lincoln

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

'On-off switch' brings researchers a step closer to potential HIV vaccine

30.03.2017 | Health and Medicine

Penn studies find promise for innovations in liquid biopsies

30.03.2017 | Health and Medicine

An LED-based device for imaging radiation induced skin damage

30.03.2017 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>